glp-1 pediatric Role of Receptor Agonists in Obesity: Benefits, Risks, and Approaches to Patient Selection | Current Obesity Reports Pharmacists Must Consider Benefits and

The difference in effectiveness could be attributed to tirzepatides GIP agonism and its more robust ability to promote weight loss

Samanc B, Samanc Y, Tzn E, et al

Tight ponytails, braids, and buns pull on hair that is already in a fragile resting phase and can cause additional loss through traction alopecia on top of the telogen effluvium

Practical Considerations for Clinicians When adding GLP1s to a liver-focused treatment plan: Evaluate contraindications (e.g., history of medullary thyroid cancer) Educate patients about common side effects and gradual dose titration Use liver biomarkers and imaging to monitor response over time Ensure cost and access considerations are addressed up front For additional guidance, consult Healthcare.pro or professional society recommendations to stay current on metabolic liver disease management

The GLP-1 receptor is a type of cell surface receptor that binds to GLP-1, triggering a signaling cascade that leads to various effects, including the stimulation of insulin secretion, the inhibition of gastric emptying, and the promotion of satiety

If you're preparing for a visit, doctor-visit prep can help you organize doses, symptoms, and recent events